Having such a rare and aggressive liver cancer – with an abysmal survival rate – was unbelievable. I was 46, fit and healthy. I exercise regularly and drink very little. I had, however ...
CHLA leads the country in one- and three-year liver graft and patient survival for pediatric liver transplants—and is among ...
In a groundbreaking medical achievement in the U.K., a 32-year-old woman from Manchester has undergone the country's first ...
The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...
Opens in a new tab or window Addition of the anti-TIGIT monoclonal antibody tiragolumab to standard first-line treatment resulted in better response rates and improved survival for patients with ...
That is about to change, with $6 million awarded to National Cancer Centre Singapore (NCCS) senior consultant surgeon Pierce ...
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback